Form 8-K - Current report:
SEC Accession No. 0001576280-21-000025
Filing Date
2021-02-24
Accepted
2021-02-24 16:11:32
Documents
16
Period of Report
2021-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gh-20210224.htm   iXBRL 8-K 38632
2 EX-99.1 gh-12312020xexhibit991.htm EX-99.1 162093
8 guardantlogoa011a.gif GRAPHIC 17260
  Complete submission text file 0001576280-21-000025.txt   382027

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gh-20210224.xsd EX-101.SCH 2516
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gh-20210224_cal.xml EX-101.CAL 805
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gh-20210224_def.xml EX-101.DEF 1769
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gh-20210224_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gh-20210224_pre.xml EX-101.PRE 12741
9 EXTRACTED XBRL INSTANCE DOCUMENT gh-20210224_htm.xml XML 10770
Mailing Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR. REDWOOD CITY CA 94063 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 21673221
SIC: 8071 Services-Medical Laboratories